Current surgical management of abdominal aortic aneurysm with concomitant malignancy in the endovascular era

• Published in: Surgery today (Tokyo, Japan) Japan), 2016-08, Vol.46 (8), p.985-994
• Main Authors: Maeda, Koji, Ohki, Takao, Kanaoka, Yuji, Toya, Naoki, Baba, Takeshi, Hara, Masayuki, Hagiwara, Shin
• Format: Article
• Language: English
• Subjects: Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal - complications; Aortic Aneurysm, Abdominal - mortality; Aortic Aneurysm, Abdominal - surgery; Chemoradiotherapy; Elective Surgical Procedures; Endovascular Procedures - methods; Female; Follow-Up Studies; Humans; Length of Stay; Male; Medicine; Medicine & Public Health; Middle Aged; Neoplasms - complications; Neoplasms - mortality; Neoplasms - therapy; Original Article; Retrospective Studies; Surgery; Surgical Oncology; Surgical Procedures, Operative; Survival Rate; Treatment Outcome
• ISSN: 0941-1291; 1436-2813
• DOI: 10.1007/s00595-015-1262-8

Purpose The management of abdominal aortic aneurysm (AAA) with concomitant malignancy is controversial in terms of which treatment should come first. The aim of this study was to evaluate the outcomes of endovascular aortic repair (EVAR) as the initial treatment prior to the treatment of malignancy for patients with AAA and concomitant malignancy. Methods EVAR for AAA was performed in 1,175 cases between April 2007 and April 2014, of which 63 patients (5.4 %) who had AAAs and malignancy were identified. The clinical details and outcomes for patients with AAA and malignancy were evaluated. Results The mean age of patients with AAA and malignancy was 76.6 years. Thirty-three patients underwent EVAR before surgery for their malignancies, and 30 patients received chemoradiotherapy following EVAR. No significant differences in the length of stay (LOS), 30-day mortality, and morbidities were observed in all groups. However, the overall survival rate of the patients who had AAA and malignancy was lower than those who had only AAA ( P